NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.40
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
2.25
Today|||52-Week Range
5.00
-11.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-16.0M-15.2M-19.0M-13.2M
 
 
 
 
 
Depreciation314.0K232.0K164.0K114.0K
 
 
 
 
 
Total Other Cash Flow1.7M-636.0K-768.0K4.1M
 
 
 
 
 
Funds From Operations-14.0M-15.6M-19.6M-9.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.0M-543.0K-1.0M3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-13.0M-15.1M-18.6M-12.1M
 
 
 
 
 
 
InvestingIncrease In Investments-4.3M-4.0M0.000.00
 
 
 
Decrease In Investments5.9M6.6M0.000.00
 
 
 
Capital Expenditures-141.0K-68.0K-123.0K-160.0K
 
 
 
 
 
Fixed Asset Disposal0.00128.0K37.0K0.00
 
 
 
Net Cash Flow Investing1.4M2.6M-86.0K-160.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.001.7M1.4M
 
 
 
Long Term Debt Reduction0.000.00---3.0M
 
 
Net Proceeds Stock Sale9.3M7.4M13.9M21.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing9.3M7.4M15.6M19.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-2.2M-5.1M-3.0M7.1M